News | August 11, 2024
HealthCare Global Enterprises posts Q1 FY25 PAT higher at Rs. 12.1 Cr
Our centers are performing as expected or even better
Our centers are performing as expected or even better
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
An accomplished R&D leader and champion of the application of AI to drug discovery
Arco Lab now holds a 50% stake in Neviton
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Subscribe To Our Newsletter & Stay Updated
